Condition
Orthostatic Hypotension
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 23 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
23 shownAutonomic Regulation of Blood Pressure and Heart Rate During Orthostasis and Exercise in Healthy and Hypertensive IndividualsNCT07482462 · 2025-10-15
RECRUITINGBlood Pressure Effects on Cognition and Brain Blood Flow in PDNCT05400174 · 2021-12-14
RECRUITINGEffects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureNCT02897063 · 2016-09-01
RECRUITINGDeciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic HypotensionNCT07139756 · 2025-10-01
NOT_YET_RECRUITINGThe Effect of Rehabilitation Training on Orthostatic Hypotension in Parkinson's PatientsNCT06328335 · 2024-04-01
UNKNOWNThe Effect of Rehabilitation Training on Orthostatic Hypotension in Parkinson's PatientsNCT06255717 · 2024-02-29
UNKNOWNEfficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic HypotensionNCT05647473 · 2024-02-20
UNKNOWNThe Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail ElderlyNCT05529147 · 2022-09-05
COMPLETEDEffect of Levodopa on Cardiovascular Autonomic Function in Parkinson's DiseaseNCT05487300 · 2022-05-11
COMPLETEDAdvancing Understanding of Transportation OptionsNCT04141891 · 2019-12-12
COMPLETEDLundbeck TOMs Orthostatic HypotensionNCT04510922 · 2019-02-11
COMPLETEDCardiovascular Effects of Exercise in Patients With Parkinson's DiseaseNCT03343574 · 2017-12-01
UNKNOWNTD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)NCT02705755 · 2017-09-09
COMPLETEDScreening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)NCT01705626 · 2016-12-01
COMPLETEDReduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in AutonomicNCT02726711 · 2016-04-01
ACTIVE_NOT_RECRUITINGInsulin Therapy and Falls Due to Orthostatic HypotensionNCT01914146 · 2015-04-01
WITHDRAWNDroxidopa / Pyridostigmine in Orthostatic HypotensionNCT01370512 · 2011-11-01
ENROLLING_BY_INVITATIONNorepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic HypotensionNCT01316666 · 2011-03-01
COMPLETEDA Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseNCT01176240 · 2010-06-01
COMPLETEDOrthostatic Hypotension and Diabetes MellitusNCT00807976 · 2009-01-01
COMPLETEDHome-Based Walking Study in Older Adults With Type 2 DiabetesNCT00824330 · 2009-01-01
COMPLETEDIs Orthostatic Hypotension Associated With Nondipping HypertensionNCT00491231 · 2007-07-01
UNKNOWNEfficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System AtrophyNCT00103597 · 2005-01-01
COMPLETEDCommon interventions
DroxidopaDRUG3PlaceboDRUG3Comprehensive rehabilitation trainingBEHAVIORAL2PlaceboOTHER2Rise-bed TrainingBEHAVIORAL2Abdominal Strengthening ExerciseOTHER1add-on high dose AstragalusDRUG1add-on low dose AstragalusDRUG1Antihypertensive AgentsDRUG1Autonomic testing on and off levodopaDRUG1Conservative Measures for Orthostatic HypotensionBEHAVIORAL1Control Phase; Exercise PhaseBEHAVIORAL1DomperidoneDRUG1Driving Decision AidBEHAVIORAL1Droxidopa 100 MG [Northera]DRUG1FludrocortisoneDRUG1InsulinOTHER1Lower body negative pressureDIAGNOSTIC_TEST1MidodrineDRUG1No InsulinOTHER1Older Drivers WebsiteBEHAVIORAL1PyridostigmineDRUG1Routine treatmentBEHAVIORAL1TD-9855DRUG1Tilt table (upright position)DIAGNOSTIC_TEST1
Leading sponsors
University of British Columbia
2
Vanderbilt University Medical Center
2
Alberto Espay, MD, MSc
1
CENTOGENE GmbH Rostock
1
Centre Hospitalier Universitaire Vaudois
1
Chelsea Therapeutics
1
Copka Sonpashan
1
Faizan Ahmed
1
Fujian Medical University Union Hospital
1
Mayo Clinic
1
Medical Research Foundation, The Netherlands
1
Radboud University Medical Center
1
Royal Brisbane and Women's Hospital
1
Sheba Medical Center
1
Theravance Biopharma
1
Trial status mix
COMPLETED11
UNKNOWN5
RECRUITING3
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1
WITHDRAWN1
Phase mix
NA7
PHASE24
PHASE13
PHASE32
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.